Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2021 ∙ Liang, Y. Jing-Xia, G. Ma, L. Ni, L. Chaolie, R. Zhou, J. Guo-Yang, L.

Immunogenicity and safety levels of inactivated quadrivalent influenza vaccine in healthy adults via meta-analysis

  • Adults
  • Influenza
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Kalaij, A. G. I. Dirjayanto, V. J. Yusuf, S. M. Nelwan, E. J.

Immunogenicity and safety of adenovirus-based vector vaccines for COVID-19: a systematic review and meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Diallo, A. Carlos-Bolumbu, M. Cervantes-Gonzalez, M. Wozniak, V. Diallo, M. H. Diallo, B. D. Delamou, A. Galtier, F.

Immunogenicity and safety of Ebola virus vaccines in healthy adults: a systematic review and network meta-analysis

  • Adults
  • Older adults
  • Ebola
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Egunsola, O. Clement, F. Taplin, J. Mastikhina, L. Li, J. W. Lorenzetti, D. L. Dowsett, L. E. Noseworthy, T.

Immunogenicity and Safety of Reduced-Dose Intradermal vs Intramuscular Influenza Vaccines: A Systematic Review and Meta-analysis

  • Adults
  • Older adults
  • Administration
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Keller, M. Pittet, L. F. Zimmermann, P.

Immunogenicity and safety of routine vaccines in children and adolescents with rheumatic diseases on immunosuppressive treatment — a systematic review

  • Children
  • Adolescents
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Lau, Oscar Vadlamudi, Nirma Khatri

Immunogenicity and Safety of the COVID-19 Vaccines Compared With Control in Healthy Adults: A Qualitative and Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Teh, Joanne S. K. Coussement, Julien Neoh, Zoe C. F. Spelman, Tim Lazarakis, Smaro Slavin, Monica A. Teh, Benjamin W.

Immunogenicity of COVID-19 vaccines in patients with hematological malignancy: a systematic review and meta-analysis

  • All age groups
  • Healthcare workers
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Zhang, K. Wu, X. Shi, Y. Gou, X. Huang, J.

Immunogenicity of H5N1 influenza vaccines in elderly adults: a systematic review and meta-analysis

  • Adults
  • Older adults
  • Influenza
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Akyol, M. Çevik, E. Ucku, D. Tanr Af Kanbay, A. Covic, A. Ortiz, A. Basile, C. Kanbay, M.

Immunogenicity of SARS-CoV-2 mRNA vaccine in dialysis and kidney transplant patients: A systematic review

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Nguyen, J. Hardigan, P. Kesselman, M. M. Demory Beckler, M.

Immunogenicity of The Influenza Vaccine in Multiple Sclerosis Patients: A Systematic Review and Meta-Analysis

  • Adults
  • Older adults
  • Influenza
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...